This contract expires in 262 days (Jan 5, 2027).
SCHAAF DRUGS, LLC - OY3 (PYP-TC99M ATRIAL AMYLOIDOSIS) CANNOT BE LOCATED ON THE PRICE SCHEDULE FOUND THAT THIS ITEM WAS INADVERTENTLY LEFT OFF THE PRICE LIST
Key Details
Description
OY3 (PYP-TC99M ATRIAL AMYLOIDOSIS) CANNOT BE LOCATED ON THE PRICE SCHEDULE FOUND THAT THIS ITEM WAS INADVERTENTLY LEFT OFF THE PRICE LIST
Context & Analysis
On Jan 2, 2026, Department of Veterans Affairs obligated $118,668 to SCHAAF DRUGS, LLC for oy3 (pyp-tc99m atrial amyloidosis) cannot be located on the price schedule found that this item was inadvertently left off the price list. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition after exclusion of sources. Performance is located in LIMA, OH. The contract is scheduled through Jan 5, 2027 — approximately 9 months remaining. This award is one of several similar procurements from Department of Veterans Affairs under NAICS 325412 — related awards are listed below.
Contractor Information
Similar Awards
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 NOVEMBER
MCKESSON CORPORATION
$1.4B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 OCTOBER
MCKESSON CORPORATION
$1.2B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 DECEMBER
MCKESSON CORPORATION
$1.1B
EXPRESS REPORT: PHARMACEUTICAL PRIME VENDOR (PPV)FY2026 JANUARY
MCKESSON CORPORATION
$1.1B
LENALIDOMIDE FOR THE SALISBURY VAMC, CHARLOTTE HCC, AND KERNERSVILLE HCC.
EXELAN PHARMACEUTICALS INC
$5.1M
Stay Updated
Get notified about new opportunities matching your interests.